LAV Biosciences Fund V, L.P.insider trades
In SEC Form 4 filings, LAV Biosciences Fund V, L.P. is listed as 10% owner of ADARx Pharmaceuticals, Inc. (ADRX). LAV Biosciences Fund V, L.P. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Sep 29.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | 10% owner | 12 | Sep 29 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-29
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 8,908,775 | not reported | not reported | 8,908,775 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 1,667,469 | not reported | not reported | 10,576,244 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 513,067 | not reported | not reported | 11,089,311 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 153,868 | not reported | not reported | 11,243,179 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 307,738 | not reported | not reported | 307,738 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C | 307,738 | not reported | not reported | 307,738 | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 10,438,412 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 1,953,774 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 601,161 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 180,288 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 360,577 | $0.00 | $0 | not reported | No | Form 4 |
| ADRXADARx Pharmaceuticals, Inc. | Sep 28 | Sep 29 | C · derivative | 360,577 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.